1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment increased: 37 → 48 participants
Tang-Du HospitalNot applicable NCT07854964 Registry history of NCT07854964 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-02 | NCT07854964 A Prospective, Single-center, Phase II Study of Neoadjuvant Serplulimab Plus XELOX and… | Not Yet Recruiting |
| Phase 1 | 2 | |
| Phase 1/2 | 5 | |
| Phase 2 | 25 | |
| Phase 3 | 2 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06467786 | Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer | Small Cell Lung Cancer | Recruiting | 2024-06-21 |
| NCT07699770 | Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled… | Neuromyelitis Optica Spectrum Disorders (NMOSD) | Not Yet Recruiting | 2026-07-13 |
| Phase 3 | ||||
| NCT07141303 | Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior… | Acute Ischemic Stroke | Recruiting | 2025-09-18 |
| NCT06952621 | Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus… | Esophageal Squamous Cell Carcinoma (ESCC) | Not Yet Recruiting | 2026-01-30 |
| Phase 2 | ||||
| NCT07452601 | Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC | Esophageal Squamous Cell Carcinoma | Recruiting | 2026-05-28 |
| NCT07596121 | Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50% | NSCLC (Non-small Cell Lung Cancer) | Recruiting | 2026-05-19 |
| NCT06065046 | Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions | Traumatic Brain Injury | Recruiting | 2026-04-13 |
| NCT07516522 | Intra-arterial Methylprednisolone After Endovascular Thrombectomy | Ischemia Stroke | Recruiting | 2026-04-08 |
| NCT07353723 | Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar… | Head & Neck Cancer | Recruiting | 2026-01-20 |
| NCT07141264 | Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy | SCLC,Extensive Stage | Recruiting | 2025-12-30 |
| NCT06864624 | Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC | NSCLC | Recruiting | 2025-07-25 |
| NCT05067348 | Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized | Recruiting | 2025-05-01 |
| NCT06663059 | Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study | Esophageal Cancer | Recruiting | 2024-10-29 |
| NCT06485544 | Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial | Small Cell Lung Cancer (SCLC) | Recruiting | 2024-07-03 |
| NCT06475209 | Adebrelimab + Apatinib in SCLC Maintenance Therapy | SCLC | Recruiting | 2024-06-26 |
| NCT06055738 | Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant… | Locally Advanced Cervical Cancer | Recruiting | 2023-09-28 |
| NCT06006650 | Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell | Neoadjuvent | Recruiting | 2023-08-23 |
| NCT05430802 | Neoadjuvant Furmonertinib and Cisplatin/Pemetrexed as in EGFR Mutated Stage IIA-IIIB… | Non-small Cell Lung Cancer | Active, Not Recruiting | 2026-09-25 |
| NCT07773363 | Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic… | Pancreatic Cancer | Not Yet Recruiting | 2026-08-19 |
| NCT07752394 | Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal… | Head & Neck Cancer | Not Yet Recruiting | 2026-08-07 |
| NCT07709767 | Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal… | Gastric Adenocarcinoma | Not Yet Recruiting | 2026-07-17 |
| NCT07678580 | Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally… | Esophageal Squamous Cell Carcinoma (ESCC) | Not Yet Recruiting | 2026-07-01 |
| NCT07618923 | Neoadjuvant Dalpiciclib + AI → SHR-A1811 for HR+/HER2-Low Breast Cancer | Breast Cancer | Not Yet Recruiting | 2026-06-11 |
| NCT07618910 | Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC | Esophageal Squamous Cell Carcinoma | Not Yet Recruiting | 2026-06-01 |
| NCT06978153 | This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart… | Limited Stage Small Cell Lung Cancer | Not Yet Recruiting | 2025-05-18 |
Lung Cancer (15) · Non-Small Cell Lung Cancer (NSCLC) (9) · Esophageal Cancer (7) · Small Cell Lung Cancer (5) · Stroke (4) · Head & Neck Cancer (3) · Myasthenia Gravis (3) · Ulcerative Colitis (3) · Breast Cancer (2) · Colorectal Cancer (2)